Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)

Diabetes Care

Volumn 30, Issue 11, 2007, Pages 2951-2956

  Bertoni, Alain G ^a,k   Wong, Nathan D ^b   Shea, Steven ^c   Ma, Shuangge ^d   Liu, Kiang ^e   Preethi, Srikanthan ^f   Jacobs Jr , David R ^g   Wu, Colin ^h   Saad, Mohammed F ⁱ   Szklo, Moyses ^j  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d YALE UNIVERSITY   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ STONY BROOK UNIVERSITY   (United States)

^j JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^k Public Health Sciences   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY; DEMOGRAPHY; DISEASE ASSOCIATION; EDUCATION; ETHNIC GROUP; ETHNICITY; FEMALE; HEALTH PROGRAM; HISPANIC; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BLOOD PRESSURE; CALCIUM; CAROTID ARTERIES; CHOLESTEROL, LDL; CONTINENTAL POPULATION GROUPS; DIABETES COMPLICATIONS; ETHNIC GROUPS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; UNITED STATES;

EID: 36049008117     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1042     Document Type: Article

References (27)

1. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
2. Gale EA: The myth of the metabolic syndrome. Diabetologia 48:1679-1683, 2005
3. Vaidya D, Szklo M, Liu K, Schreiner PJ, Bertoni AG, Ouyang P: Defining the metabolic syndrome construct: Multi-Ethnic Study of Atherosclerosis cross-sectional analysis. Diabetes Care (ePub ahead of print)
4. Reaven GM: Banting lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438, 2004
6. Wong ND, Sciammarella MG, Polk D, Gallagher A, Miranda-Peats L, Whitcomb B, Hachamovitch R, Friedman JD, Hayes S, Berman DS: The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll-Cardiol 41:1547-1553, 2003
7. Kullo IJ, Cassidy AE, Peyser PA, Turner ST, Sheedy PF, Bielak LF: Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults. Am J Cardiol 94:1554-1558, 2004
8. Tzou WS, Douglas PS, Srinivasan SR, Bond MG, Tang R, Chen W, Berenson GS, Stein JH: Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol 46:457-463, 2005
9. Skilton MR, Moulin P, Serusclat A, Nony P, Bonnet F: A comparison of the NCEP-ATP III, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis 190:416-422, 2007
10. McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C: Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (the ARIC study). Am J Cardiol 94:1249-1254, 2004
11. Ellison RC, Zhang Y, Wagenknecht LE, Eckfeldt JH, Hopkins PN, Pankow JS, Djousse L, Carr JJ: Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta. Am J Cardiol 95:1180-1186, 2005
12. Kawamoto R, Tomita H, Inoue A, Ohtsuka N, Kamitani A: Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men. J Atheroscler Thromb 14:36-43, 2007
13. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP: Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156:871-881, 2002
14. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735-2752, 2005
17. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA: Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke 22:1155-1163, 1991
18. Czernichow S, Bertrais S, Blacher J, Oppert JM, Galan P, Ducimetiere P, Hercberg S, Safar M, Zureik M: Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular Study. Am J Hypertens 18:1154-1160, 2005
19. Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon H, Hanaire-Broutin H, Ferrieres J: Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 186:345-353, 2006
20. Hidvegi T, Szatmari F, Hetyesi K, Biro L, Jermendy G: Intima-media thickness of the carotid arteries in subjects with hyper-insulinaemia (insulin resistance). Diabetes Nutr Metab 16:139-144, 2003
21. Wohlin M, Sundstrom J, Arnlov J, Andren B, Zethelius B, Lind L: Impaired insulin sensitivity is an independent predictor of common carotid intima-media thickness in a population sample of elderly men. Atherosclerosis 170:181-185, 2003
22. Bokemark L, Wikstrand J, Attvall S, Hulthe J, Wedel H, Fagerberg B: Insulin resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men: the Atherosclerosis and Insulin Resistance Study (AIR). J Intern Med 249:59-67, 2001
23. Yang B, Li TD, Wang JS, Zhi G, Jin WS, Xu Y: Insulin resistance and carotid atherosclerosis in 221 patients with hyperglycemia. Chin Med Sci 20:108-111, 2005
24. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R: Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) investigators. Circulation 93:1809-1817, 1996
25. Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ: Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 110:803-809, 2004
26. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54:3252-3257, 2005
27. Kohli P, Greenland P: Role of the metabolic syndrome in risk assessment for coronary heart disease. JAMA 295:819-821, 2006